- Home
- LRMR vs MVBF Comparison
LRMR vs MVBF Comparison
Compare LRMR & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LRMR | MVBF |
|---|---|---|
| Founded | N/A | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.1M | 351.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LRMR | MVBF |
|---|---|---|
| Price | $3.41 | $28.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $16.71 | ★ $27.60 |
| AVG Volume (30 Days) | ★ 1.4M | 79.3K |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 2.45% |
| EPS Growth | N/A | ★ 73.99 |
| EPS | N/A | ★ 2.45 |
| Revenue | N/A | ★ $167,853,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.06 |
| P/E Ratio | ★ N/A | $11.34 |
| Revenue Growth | N/A | ★ 18.75 |
| 52 Week Low | $1.61 | $15.59 |
| 52 Week High | $5.37 | $28.72 |
Technical Indicators
Market Signals| Indicator | LRMR | MVBF |
|---|---|---|
| Relative Strength Index (RSI) | 44.05 | 64.74 |
| Support Level | $3.12 | $26.52 |
| Resistance Level | $4.15 | $28.72 |
| Average True Range (ATR) | 0.27 | 0.73 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 37.38 | 86.03 |
Price Performance
Historical ComparisonAbout LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.